A leading Chinese COVID-19 vaccine candidate has been found to be 50.4 percent effective, according to the results of a late-stage trial in Brazil, a potential setback to the Chinese regime as it seeks to leverage the vaccine to boost its global image. The results from Brazil’s state-funded Butantan Institute on Jan. 12 were just…
Chinese Vaccine Found to Be 50.4 Percent Effective in Brazil Trial
January 13, 2021
admin
AmericasBrazilCCP VirusChinaChinese RegimeChinese vaccineCoronaVacInternationalPUBLIC HEALTH INFORMATIONSinovacWorld
0 Comment
Chinese COVID-19 Vaccine Shows 50.4 Percent Efficacy in Brazil Trial
January 13, 2021
admin
AmericasBrazilCCP VirusChinaChinese RegimeChinese vaccineCoronaVacInternationalPUBLIC HEALTH INFORMATIONSinovacWorld
0 Comment
A leading Chinese COVID-19 vaccine candidate has been found to be 50.4 percent effective, according to the results of a late-stage trial in Brazil, a potential setback to the Chinese regime as it seeks to leverage the vaccine to boost its global image. The results from Brazil’s state-funded Butantan Institute on Jan. 12 were just…
Brazil Finds Chinese Vaccine to Be 50.4% Effective, Far Lower Than Initial Claims
January 13, 2021
admin
AmericasBrazilCCP VirusChinaChinese RegimeChinese vaccineCoronaVacInternationalPUBLIC HEALTH INFORMATIONSinovacWorld
0 Comment
A leading Chinese vaccine has been found to be 50.4 percent effective, according to the results of a late-stage trial in Brazil, serving a blow to the Chinese regime as it seeks to leverage the vaccine to bolster its global image. The results from Brazil’s state-funded Butantan Institute on Tuesday were just enough to pass…
China Insider: Sinovac Delays Release of Vaccine Trials, Effectiveness Questioned
Chinese company Sinovac Biotech Ltd. is delaying the release of the results of a phase III clinical trial of its CCP virus vaccine until January. Before that, Sinovac had delayed its announcement twice, which raised questions about the effectiveness of the vaccine.
Beijing Mandates Millions to Get China-Made COVID-19 Vaccine as Testing Continues
The Chinese regime recently mandated that 50 million doses of COVID-19 vaccines must be administered to people designated as high-risk by Feb. 15, 2021—although drug companies have not yet completed testing and the vaccines have yet to be approved by regulators. Meanwhile, Fosun Pharmaceutical announced that it ordered 100 million doses of the COVID-19 vaccine…
Beijing Mandates Millions Must Get China-Made COVID-19 Vaccine as Testing Continues
The Chinese regime recently mandated that 50 million doses of COVID-19 vaccines must be administered to people designated as high risk by Feb. 15, 2021—although drug companies have yet to complete testing and the vaccines have yet to be approved by regulators. Meanwhile, Fosun Pharmaceutical announced that it had ordered 100 million doses of the…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`